GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:15215188

From GONUTS
Jump to: navigation, search
Citation

Kanellis, J, Garcia, GE, Li, P, Parra, G, Wilson, CB, Rao, Y, Han, S, Smith, CW, Johnson, RJ, Wu, JY and Feng, L (2004) Modulation of inflammation by slit protein in vivo in experimental crescentic glomerulonephritis. Am. J. Pathol. 165:341-52

Abstract

A basic conservation of cell migration guidance mechanisms in the nervous and immune systems was proposed when Slit, known for its role in axon guidance, was found to inhibit chemokine-induced leukocyte chemotaxis in vitro. These studies examined the role of Slit2 in modulating inflammation in vivo. In a rat model of glomerulonephritis, endogenous glomerular Slit2 expression fell after disease induction, and its inhibition during the early disease period accelerated inflammation. Ex vivo glomerular leukocytes showed decreased chemokine and chemoattractant-induced chemotaxis in response to Slit2, suggesting an anti-inflammatory role for glomerular Slit2. In contrast to the effect of inhibition, glomerulonephritis was ameliorated by systemic Slit2 administration. Slit2 treatment improved disease histologically and also improved renal function when given early in the disease course. Leukocytes harvested from rats receiving Slit2 showed decreased monocyte chemoattractant protein-1 (MCP)-1-mediated migration, consistent with a peripheral Slit2 effect. In keeping with this functional alteration, Slit2-mediated inhibition of RAW264.7 cell chemotaxis was associated with decreased levels of active cdc42 and Rac1, implicating GTPases in leukocyte Slit2 signaling. These findings suggest a role for endogenous Slit2 in the inhibition of chemoattractant-mediated signals, demonstrate a potentially important anti-inflammatory effect for Slit2 in vivo, and provide further evidence for conserved mechanisms guiding the process of migration in distinct cell types.

Links

PubMed PMC1618548 Online version:10.1016/S0002-9440(10)63301-9

Keywords

Animals; Antigens, CD/metabolism; Blotting, Western; Cell Line; Chemokine CCL2/metabolism; Chemotaxis, Leukocyte/drug effects; Disease Models, Animal; Down-Regulation; Flow Cytometry; Gene Expression Regulation/drug effects; Glomerulonephritis/etiology; Glomerulonephritis/metabolism; Glomerulonephritis/pathology; Glomerulonephritis/physiopathology; Inflammation/drug therapy; Intercellular Signaling Peptides and Proteins; Leukocytes, Mononuclear/drug effects; Male; Nerve Tissue Proteins/administration & dosage; Nerve Tissue Proteins/metabolism; RNA, Messenger/metabolism; Rats; Rats, Inbred WKY; Recombinant Proteins/administration & dosage; Recombinant Proteins/metabolism; Reverse Transcriptase Polymerase Chain Reaction; rac1 GTP-Binding Protein/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

RAT:SLIT2

GO:0050728: negative regulation of inflammatory response

ECO:0000315:

P

complete

RAT:SLIT2

involved_in

GO:0050728: negative regulation of inflammatory response

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete


See also

References

See Help:References for how to manage references in GONUTS.